Care Management


The pay-for-performance model has come a long way in terms of how physicians are taking care of larger patients populations, according to Mitzi Wasik, PharmD, BCPS, director of Pharmacy Medicare Programs at Aetna, Inc.
Drug pricing for specialty pharmaceuticals and other advanced technology is the topic of discussion for panelists Francois de Brantes, MS, MBA, Ateev Mehrotra, MD, MPH, and Arthur Vercillo MD, FACS, in this 14th installment of the Healthcare Reform Stakeholders Summit, conducted in April 2015.
During this segment, Michael A. Evans, BS, RPh, discusses why patient follow-up is necessary during transitions of care scenarios after initiating therapy with an anticoagulant.
The authors undertook a literature search on treatment intensification in diabetes care to identify relevant research that has been published since 2000.
Approximately 9 million Medicare beneficiaries are considered “complex care” and they often incur high out-of-pocket costs. As lifespans lengthen, it becomes important for Medicare to adapt to serve these complex care beneficiaries.


October 17 - 18, 2014
Boston, MA
Diabetes Compendium
Oncology Compendium